ArticleThe Journal of clinical investigation2019

HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Alejandro A Pezzulo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.